Shuhong Wang

Dr Shuhong Wang

Grant-Funded Researcher (B)

School of Public Health

Faculty of Health and Medical Sciences


Dr. Shuhong Wang is a Team Leader within AHTA who are responsible for evaluation of pharmaceutical industry submissions to the Pharmaceutical Benefits Advisory Committee. She has a PhD in Public Health (major in Health Economics) from the University of Adelaide. She also has a medical degree as well as a Masters in Medical Sciences from China. She is a Health Economist by training, with a background in epidemiology and experiences in economic modelling.

Areas of Research Interest

Economic evaluation of health technologies and interventions, evidence-based policy making, health insurance scheme, and essential medicine and pharmaceuticals policies.

  • Appointments

    Date Position Institution name
    2007 - ongoing Team Leader, Pharmaceutical Evaluation University of Adelaide
    2004 - 2007 Senior Research Officer, Adelaide Health Technology Assessment University of Adelaide
    2003 - 2004 Tutor University of Adelaide
    1997 - 2002 Lecturer Shandong University
    1995 - 1997 Associate Lecturer Shandong Medical University
  • Education

    Date Institution name Country Title
    University of Adelaide Australia PhD in Public Health (Epidemiology and Health Economics)
    Shandong Medical University China Masters of Medical Sciences (Social Medicine and Health Economics)
    Shandong Medical University China Bachelor of Medicine (Public Health)
  • Research Interests

  • Journals

    Year Citation
    2020 Baghbanian, A., Merlin, T., Carter, D., & Wang, S. (2020). Methods for the Health Technology Assessment of Complex Interventions: A Protocol for a Scoping Review. BMJ Open.
    2018 Wang, S., Gum, D., & Merlin, T. L. (2018). Comparing the ICERs in medicine reimbursement submissions to NICE and PBAC – does the presence of an explicit threshold affect the ICER proposed?. Value in Health, 21(8), 938-943.
    DOI Scopus28 WoS24 Europe PMC5
    2011 Wang, S., Moss, J., & Hiller, J. (2011). The cost-effectiveness of HIV voluntary counseling and testing in China. Asia-Pacific Journal of Public Health, 23(4), 620-633.
    DOI Scopus12 WoS12 Europe PMC11
    2009 Wang, S., Merlin, T., Kreisz, F., Craft, P., & Hiller, J. (2009). Cost and cost-effectiveness of digital mammography compared with film-screen mammography in Australia. Australian and New Zealand Journal of Public Health, 33(5), 430-436.
    DOI Scopus5 WoS2 Europe PMC3
    2006 Wang, S., Moss, J., & Hiller, J. (2006). Applicability and transferability of interventions in evidence-based public health. Health Promotion International, 21(1), 76-83.
    DOI Scopus145 WoS135 Europe PMC88
  • Conference Items

    Year Citation
    2013 Newton, S., Wang, S., Schubert, C., & Merlin, T. (2013). One small step for an individual, one giant leap for their family: considerations required for assessing the cost effectiveness of genetic tests. Poster session presented at the meeting of the 10th Annual Health Technology Assessment international (HTAi) Conference. Seoul, South Korea.
    2010 Buckley, E., Wang, S., Merlin, T. L., & Hiller, J. E. (2010). Use of disease prevalence when estimating the positive predictive value of a test can mislead: the spectrum effect. Poster session presented at the meeting of the 7th Annual Health Technology Assessment international (HTAi) Conference. Dublin, Ireland.
    2009 Wang, S., Gum, D., Merlin, T. L., & Hiller, J. E. (2009). Predictors of vaccination uptake and course completion: A systematic review. Poster session presented at the meeting of the 6th Annual Health Technology Assessment international (HTAi) Conference. Singapore.
    2008 Wang, S., Merlin, T. L., Kreisz, F., Craft, P., & Hiller, J. E. (2008). Cost-effectiveness of digital mammography compared with film-screen mammography in Australia. Poster session presented at the meeting of the Population Health Congress. Brisbane, QLD.
    2008 Merlin, T. L., Newton, S., Wang, S., & Hiller, J. E. (2008). Technology assessment in the context of workforce shortages and changing supply: digital mammography. Poster session presented at the meeting of the 5th Annual Health Technology Assessment international (HTAi) Conference. Montreal, Canada.
  • Report for External Bodies

    Year Citation
    2012 Morona, J. K., Newton, S., Wang, S., Tamblyn, D., Ellery, B., & Merlin, T. (2012). Genetic testing for hereditary mutations in the VHL gene that cause von Hippel-Lindau syndrome (MSAC Application number 1153,). Canberra, ACT.: Commonwealth of Australia.
    2012 Docter, S., Newton, S., Wang, S., Merlin, T. L., Ellery, B., Milverton, J., & Ma, N. (2012). Genetic testing for the diagnosis or prediction of long QT syndrome. Commonwealth of Australia, Canberra, ACT, 2012. ISSN (online) 1443-7139. [on hold at applicant’s request].

Competitive Research Funding

National Competitive Schemes

 
Date Project/No. Investigators Funding Body Amount
2012 - 2016 Pharmaceutical Benefits Branch, Australian Government Department of Health and Ageing. External evaluation of industry submissions to the Pharmaceutical Benefits Advisory Committee. Merlin T, Moss J, Wang S, Schubert C.   $5,455,151.
  • Memberships

    Date Role Membership Country
    2016 - ongoing Member Member of International Society for Pharmacoeconomics and Outcomes Research
    2014 - ongoing Member Member of Health Services Research Association of Australia and New Zealand
  • Position: Grant-Funded Researcher (B)
  • Phone: 83136503
  • Email: shuhong.wang@adelaide.edu.au
  • Campus: North Terrace
  • Building: Rundle Mall Plaza, floor 4
  • Org Unit: Adelaide Health Technology Assessment

Connect With Me
External Profiles